# Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.

> **NCT04566211** · NA · UNKNOWN · sponsor: **Kaohsiung Veterans General Hospital.** · enrollment: 440 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** (panto+amox+clar+metr)+(panto+amox)
- **DRUG:** pantoprazole+bismuth+amox+clar

## Key facts

- **NCT ID:** NCT04566211
- **Lead sponsor:** Kaohsiung Veterans General Hospital.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2020-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04566211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04566211, "Comparing the Efficacy of 10-day Reverse Hybrid Therapy and 10-day Triple Therapy Plus Bismuth Therapy.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04566211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*